LungLife AI, Inc.
LLAI.L · LSE
6/30/2024 | 12/31/2023 | 6/30/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | £5,743 | £14,924 | £8,249 | £26,178 |
| - Cash | £2,619 | £2,724 | £2,589 | £3,088 |
| + Debt | £211 | £346 | £474 | £601 |
| Enterprise Value | £3,335 | £12,546 | £6,134 | £23,691 |
| Revenue | £6 | £23 | £23 | £14 |
| % Growth | -73.9% | 0% | 64.3% | – |
| Gross Profit | £6 | £23 | £23 | £14 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -£1,768 | -£2,594 | -£2,784 | -£3,143 |
| % Margin | -29,466.7% | -11,278.3% | -12,104.3% | -22,450% |
| Net Income | -£1,861 | -£2,606 | -£2,807 | -£3,137 |
| % Margin | -31,016.7% | -11,330.4% | -12,204.3% | -22,407.1% |
| EPS Diluted | -0.066 | -0.102 | -0.11 | -0.123 |
| % Growth | 35.8% | 7.3% | 10.6% | – |
| Operating Cash Flow | -£1,944 | -£2,320 | -£2,700 | -£2,580 |
| Capital Expenditures | -£5 | -£72 | -£5 | -£3 |
| Free Cash Flow | -£1,949 | -£2,392 | -£2,705 | -£2,583 |